GlycoMimetics Email Format

Pharmaceutical ManufacturingMaryland, United States11-50 Employees

GlycoMimetics is a late-stage biotechnology company focused on discovering and developing glycobiology-based therapies to address cancers and inflammatory diseases, including acute myeloid leukemia and sickle cell disease. Its work centers on understanding how carbohydrates influence cell recognition and using a proprietary chemistry platform to create small-molecule glycomimetics that modulate carbohydrate-mediated interactions across various disease states. The company aims to advance wholly-owned drug candidates from research through late-stage clinical development, leveraging development and commercial capabilities to move therapies toward patient care. Headquartered in Rockville, Maryland, GlycoMimetics operates within the pharmaceutical manufacturing industry and is publicly traded on NASDAQ under the ticker GLYC. A recent strategic development involves a merger with Crescent Biopharma, reflecting a shift in its corporate trajectory.

Get verified GlycoMimetics emails free

Company overview Employee directory